AVITA Medical (RCEL) Cash from Operations (2019 - 2025)
AVITA Medical filings provide 7 years of Cash from Operations readings, the most recent being 5438000.0 for Q4 2025.
- On a quarterly basis, Cash from Operations rose 32.71% to 5438000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 31195000.0, a 36.26% increase, with the full-year FY2025 number at 31195000.0, up 36.26% from a year prior.
- Cash from Operations hit 5438000.0 in Q4 2025 for AVITA Medical, down from 5219000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 572000.0 in Q3 2021 to a low of 20864000.0 in Q1 2024.
- Median Cash from Operations over the past 5 years was 9073000.0 (2023), compared with a mean of 8976470.59.
- Biggest five-year swings in Cash from Operations: skyrocketed 92.58% in 2021 and later tumbled 216.15% in 2023.
- AVITA Medical's Cash from Operations stood at 572000.0 in 2021, then crashed by 500.7% to 3436000.0 in 2022, then tumbled by 216.15% to 10863000.0 in 2023, then rose by 25.61% to 8081000.0 in 2024, then soared by 32.71% to 5438000.0 in 2025.
- The last three reported values for Cash from Operations were 5438000.0 (Q4 2025), 5219000.0 (Q3 2025), and 10229000.0 (Q2 2025) per Business Quant data.